Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RCUS
Stock Latest News
The Fly
Arcus Biosciences assumed with a Buy at Truist
4d ago
RCUS
Premium
The Fly
Arcus Biosciences price target raised to $22 from $20 at Morgan Stanley
11d ago
RCUS
Premium
Company Announcements
Arcus Biosciences Bets Big on Cascadifan
17d ago
RCUS
Premium
Company Announcements
Arcus Advances Quemliclustat With Completed Phase 1 Metabolism Study
20d ago
RCUS
Premium
The Fly
Arcus Biosciences rises 12.2%
1M ago
RCUS
Premium
The Fly
Merck setback has positives and negatives for Arcus Biosciences, says BofA
1M ago
MRK
RCUS
Premium
The Fly
Merck study miss not a read for Arcus, says H.C. Wainwright
1M ago
MRK
RCUS
Premium
Ratings
Arcus Biosciences: Buy Rated on Pipeline Control, PD‑1 Backbone Validation, and Upside from Emerging I&I and RCC Programs
1M ago
RCUS
Premium
Ratings
Balanced Risk Profile After TIGIT Failure and Gilead Exit Supports Neutral Stance on Arcus
1M ago
RCUS
Premium
The Fly
Arcus Biosciences discontinues Star-121 study with Gilead due to futility
1M ago
GILD
RCUS
Premium
The Fly
Arcus Biosciences price target lowered to $47 from $49 at Leerink
1M ago
GILD
RCUS
Premium
Company Announcements
Arcus Ends Key Lung Cancer Trials in Gilead Partnership Reset
1M ago
8K
RCUS
Premium
The Fly
Wedbush raises Arcus Biosciences price target to $41, adds to Best Ideas List
2M ago
RCUS
Premium
Company Announcements
Arcus Biosciences Announces COO Resignation and Transition Plan
2M ago
8K
RCUS
Premium
The Fly
Damora Therapeutics appoints Jennifer Jarrett as CEO
2M ago
DMRA
RCUS
Premium
The Fly
Arcus Biosciences price target raised to $45 from $44 at Citi
3M ago
RCUS
Premium
Ratings
Arcus Biosciences: Casdatifan’s Differentiated HIF-2α Profile Versus Belzutifan Supports High-Risk Buy Rating
3M ago
RCUS
Premium
The Fly
Arcus Biosciences price target raised to $49 from $36 at Leerink
3M ago
RCUS
Premium
Company Announcements
Arcus Biosciences Highlights Casdatifan Momentum in Call
3M ago
RCUS
Premium
The Fly
Arcus Biosciences reports Q4 EPS (89c), consensus ($1.08)
3M ago
RCUS
Premium
The Fly
Arcus Biosciences files automatic mixed securities shelf
3M ago
RCUS
Premium
Ratings
Buy Rating on Arcus Biosciences Driven by Best-in-Class Casdatifan Data in Renal Cell Carcinoma and Favorable Phase 3 Risk‑Reward
3M ago
RCUS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
